Cefixime FrostPharma 20 mg/ml granules for oral suspension (cefixime)
Third generation cephalosporins, ATC code: J01DD08. Rx, EF Indications: For the treatment of acute bacterial sinusitis, acute mediaotitis, pharyngotonsillitis, acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infection and acute pyelonephritis in children older than 6 months and adolescents and adults, and only when it is considered inappropriate to use other antibacterial drugs commonly recommended for the treatment of these infections and when antibacterial susceptibility is confirmed. Contraindications: Hypersensitivity to the active substance, to any excipient or to cephalosporin-containing antibacterial medicines. Severe hypersensitivity to any other type of antibacterial medicine in the beta-lactam group. Warnings and precautions: Consider the risk of life-threatening pseudomembranous colitis in patients who develop severe and persistent diarrhea during or after treatment. Prolonged use may result in overgrowth of non-susceptible organisms. Severe skin reactions have been reported. Monitor renal function during combination therapy with aminoglycoside antibiotics, polymyxin B, colistin or high-dose loop diuretics. Concomitant treatment with anticoagulants may increase prothrombin times. A false positive reaction for glucose in urine may occur with Benedicts/Fehlings solutions or with copper sulphate test tablets. False positive direct antiglobulin test/Coombs test has been seen. Tests with nitroprusside may give false positive results for ketones in urine. Contains sucrose, inform patients with diabetes mellitus. Should not be used by patients with fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency. Should not be used in pregnant women unless necessary. For further information and prices, see fass.se. Based on SmPC approved 2024-12-12. For questions or reporting of side effects or complaints - contact regulatory@frostpharma.com. FrostPharma AB, www.frostpharma.com
